Luoyang Wang

941 total citations
31 papers, 746 citations indexed

About

Luoyang Wang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Luoyang Wang has authored 31 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Immunology. Recurrent topics in Luoyang Wang's work include Gut microbiota and health (11 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Ginseng Biological Effects and Applications (5 papers). Luoyang Wang is often cited by papers focused on Gut microbiota and health (11 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Ginseng Biological Effects and Applications (5 papers). Luoyang Wang collaborates with scholars based in China, United States and Russia. Luoyang Wang's co-authors include Guoqiang Jiang, Zheng Liu, Nan Jing, Wei Liang, Wenfeng Zeng, Fayun Zhang, Xiaozhe Yin, Xiuli Wei, Qin Yan and Luyao Wang and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Biomaterials.

In The Last Decade

Luoyang Wang

30 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luoyang Wang China	16	410	181	180	143	61	31	746
Jia Yang China	17	507 1.2×	182 1.0×	105 0.6×	244 1.7×	54 0.9×	40	965
Joon‐Suk Park South Korea	17	337 0.8×	89 0.5×	161 0.9×	91 0.6×	101 1.7×	45	786
Wei‐Jiunn Lee Taiwan	15	457 1.1×	69 0.4×	127 0.7×	173 1.2×	77 1.3×	25	771
Haloom Rafehi Australia	15	585 1.4×	72 0.4×	124 0.7×	110 0.8×	48 0.8×	32	1.0k
Giuseppe Ercolano Italy	19	288 0.7×	405 2.2×	202 1.1×	95 0.7×	58 1.0×	39	934
Kathleen L. Tober United States	19	338 0.8×	161 0.9×	143 0.8×	77 0.5×	46 0.8×	31	977
Yanliang Lin China	21	532 1.3×	156 0.9×	151 0.8×	229 1.6×	49 0.8×	48	1.1k
Shravanti Mukherjee India	15	513 1.3×	134 0.7×	277 1.5×	198 1.4×	47 0.8×	25	880
Eun Hee Yi South Korea	14	329 0.8×	130 0.7×	256 1.4×	131 0.9×	40 0.7×	18	720
Hwan‐Mook Kim South Korea	19	502 1.2×	119 0.7×	93 0.5×	194 1.4×	45 0.7×	43	897

Countries citing papers authored by Luoyang Wang

Since Specialization

Citations

This map shows the geographic impact of Luoyang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luoyang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luoyang Wang more than expected).

Fields of papers citing papers by Luoyang Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luoyang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luoyang Wang. The network helps show where Luoyang Wang may publish in the future.

Co-authorship network of co-authors of Luoyang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Luoyang Wang. A scholar is included among the top collaborators of Luoyang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luoyang Wang. Luoyang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Guixian, Wei Li, Suli Jiang, et al.. (2025). ARA290, an alternative of erythropoietin, inhibits activation of NLRP3 inflammasome in schwann cells after sciatic nerve injury. European Journal of Pharmacology. 997. 177610–177610. 1 indexed citations

Zhou, Mengting, Cuiping Li, Wěi Li, et al.. (2025). INSL3 promotes macrophage polarization to an immunosuppressive phenotype via the cAMP downstream signaling pathway and Akt/mTOR pathway. International Immunopharmacology. 154. 114540–114540. 1 indexed citations

Li, Wei, Guixian Liu, Jie Liang, et al.. (2025). The Dance Between Schwann Cells and Macrophages During the Repair of Peripheral Nerve Injury. Neuroscience Bulletin. 41(8). 1448–1462. 1 indexed citations

Jiang, Suli, Wei Li, Meiying Song, et al.. (2024). CXCL1-CXCR2 axis mediates inflammatory response after sciatic nerve injury by regulating macrophage infiltration. Molecular Immunology. 169. 50–65. 8 indexed citations

Wang, Luoyang, et al.. (2024). FOXM1 mediates methotrexate resistance in osteosarcoma cells by promoting autophagy. Acta Biochimica et Biophysica Sinica. 56(9). 1289–1299. 2 indexed citations

Song, Meiying, Luoyang Wang, Suli Jiang, et al.. (2024). Pathogenic Th17 cell-mediated liver fibrosis contributes to resistance to PD-L1 antibody immunotherapy in hepatocellular carcinoma. International Immunopharmacology. 129. 111601–111601. 8 indexed citations

Jing, Nan, et al.. (2023). Enhancing therapeutic effects of murine cancer vaccine by reshaping gut microbiota with Lactobacillus rhamnosus GG and jujube powder. Frontiers in Immunology. 14. 1195075–1195075. 9 indexed citations

Zhang, Fayun, Luoyang Wang, Wenfeng Zeng, et al.. (2023). PKC-ζ mediated reduction of the extracellular vesicles-associated TGF-β1 overcomes radiotherapy resistance in breast cancer. Breast Cancer Research. 25(1). 38–38. 9 indexed citations

Song, Meiying, Jie Liang, Luoyang Wang, et al.. (2023). IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment. International Immunopharmacology. 123. 110757–110757. 30 indexed citations

10.

Jiang, Suli, Jie Liang, Wei Li, et al.. (2023). The role of CXCL1/CXCR2 axis in neurological diseases. International Immunopharmacology. 120. 110330–110330. 21 indexed citations

11.

Jing, Nan, et al.. (2022). Sex-Biased Immune Responses to Antibiotics during Anti-PD-L1 Treatment in Mice with Colon Cancer. Journal of Immunology Research. 2022. 1–26. 5 indexed citations

12.

Li, Wei, Jie Liang, Shaohua Li, et al.. (2022). Research progress of targeting NLRP3 inflammasome in peripheral nerve injury and pain. International Immunopharmacology. 110. 109026–109026. 37 indexed citations

13.

Wang, Luoyang, Guoqiang Jiang, Nan Jing, et al.. (2021). Downregulating testosterone levels enhance immunotherapy efficiency. OncoImmunology. 10(1). 1981570–1981570. 10 indexed citations

14.

Jing, Nan, et al.. (2021). Jujube Powder Enhances Cyclophosphamide Efficiency against Murine Colon Cancer by Enriching CD8+ T Cells While Inhibiting Eosinophilia. Nutrients. 13(8). 2700–2700. 15 indexed citations

15.

Jing, Nan, et al.. (2021). Ultrafine Jujube Powder Enhances the Infiltration of Immune Cells during Anti-PD-L1 Treatment against Murine Colon Adenocarcinoma. Cancers. 13(16). 3987–3987. 20 indexed citations

16.

Zhang, Fayun, Apurba Kumar Barman, Zihao Wang, et al.. (2021). Optimal combination treatment regimens of vaccine and radiotherapy augment tumor-bearing host immunity. Communications Biology. 4(1). 78–78. 13 indexed citations

17.

Yin, Xiaozhe, Wenfeng Zeng, Bowen Wu, et al.. (2020). PPARα Inhibition Overcomes Tumor-Derived Exosomal Lipid-Induced Dendritic Cell Dysfunction. Cell Reports. 33(3). 108278–108278. 131 indexed citations

18.

Zhang, Chao, Wenfeng Zeng, Yi Yao, et al.. (2018). Naringenin Ameliorates Radiation-Induced Lung Injury by Lowering IL-1β Level. Journal of Pharmacology and Experimental Therapeutics. 366(2). 341–348. 40 indexed citations

19.

Zhang, Fayun, Wenjuan Dong, Wenfeng Zeng, et al.. (2016). Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation. Breast Cancer Research. 18(1). 38–38. 82 indexed citations

20.

Fang, Xiaocui, Tao Yang, Luoyang Wang, et al.. (2015). Nano-cage-mediated refolding of insulin by PEG-PE micelle. Biomaterials. 77. 139–148. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact